Nasopharyngeal Cancer Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

Nasopharyngeal Cancer Market Analysis

Over the next few years, the market for nasopharyngeal cancer is expected to grow at a CAGR of 2.7%.

The COVID-19 pandemic impacted the global nasopharyngeal cancer (NPC) market. For instance, a November 2021 article by NCBI stated that the COVID-19 period saw a delay in the diagnosis of head and neck malignancies in comparison to the pre-COVID-19 period.Thus, the decrease in diagnosis of such patients reduced the number of surgeries and treatments, thereby affecting the market demand for the therapies among the end users. However, in the current scenario, it was expected that with the decreasing COVID-19 cases and the reopening of surgical and diagnosis centers globally, the market would witness significant growth over the forecast period.

The growth of the studied market is being fueled by the increasing number of cases of nasopharyngeal cancer and the growing awareness of treatment and diagnosis among the general public. Both of these things are expected to keep the market growing.

The American Cancer Society's revised data, released in August 2022, reported that throughout life, the risk of NPC increases slowly, but people of any age get the disease, including children. In places with a high risk of NPC, like China, people are often diagnosed between 45 and 59 years old, when they are at their peak. In places with a low risk of NPC, like the United States, cases are more common in young adults (15 to 24 years old), then drop until another peak between 65 and 79 years old.

Also, the source mentioned above says that NPC is much more common in some parts of South Asia, the Middle East, and North Africa.Native Americans in the Arctic also experience it more frequently. Additionally, the World Cancer Research Fund International (WCRF) data updated in 2022 shows that NPC is the 22nd most prevalent cancer in the world, and in terms of prevalence, it ranks 22nd among cancers in women and 18th among cancers in men. As per the WCRF, around 133,000 new NPC cases were diagnosed globally in 2020. Thus, to coordinate with the disease burden, the government and major companies are focusing more on developing therapies and drugs. This is anticipated to drive market growth.

During the analysis period, the market also grew because there were more research and development (R&D) activities, collaborations, strategic partnerships, product approvals, and product launches.For instance, the Food and Drug Administration (FDA) accepted a biologics license application (BLA) in July 2022 for toripalimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced recurrent or metastatic nasopharyngeal carcinoma.The BLA will be reviewed over the next 6 months, with a prescription drug user-free act date of December 23, 2022, and a launch in the first quarter of 2023 after the approval. Thus, such developments in the market are anticipated to fuel market growth.

So, the studied market is likely to grow because there are more cases of nasopharyngeal cancer and more people are becoming aware of how to treat and diagnose the disease. But the high costs and bad side effects of the treatments are likely to slow the growth of the market over the next few years.

Nasopharyngeal Cancer Market Trends

This section covers the major market trends shaping the Nasopharyngeal Cancer Market according to our research experts:

Chemotherapy Segment is Expected to Witness Significant Growth Over the Forecast Period

To understand key trends, Download Sample Report

Nasopharyngeal Cancer Industry Segmentation

As per the scope of the report, nasopharyngeal cancer is a disease in which cancer cells form in the tissues of the nasopharynx (the upper part of the throat behind the nose). The risk of nasopharyngeal cancer can be affected by many things, including one's race and whether or not they have been exposed to the Epstein-Barr virus. Therapy (Chemotherapy, Immunotherapy, Radiation Therapy, and Others), End User (Hospitals and Clinics, Ambulatory Surgery Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America) are the segments of the Nasopharyngeal Cancer Market. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

Report scope can be customized per your requirements. Click here.